scispace - formally typeset
Open AccessJournal ArticleDOI

Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

TLDR
MR imaging-PDFF showed promise for assessment of hepatic steatosis grade in patients with NAFLD, and was significantly correlated with histologic steatotic grade.
Abstract
MR imaging with proton density fat fraction (PDFF) permitted high overall accuracy with moderate sensitivity and high specificity for classification of dichotomized steatosis grade, and these results support the conduct of further studies to help validate MR imaging–PDFF as a biomarker of hepatic steatosis in nonalcoholic fatty liver disease.

read more

Citations
More filters
Journal ArticleDOI

Diffüz Karaciğer Hastalıkları

TL;DR: Diffüz karaciğer hastalıkları (DKH) as discussed by the authors, farklı nedenlerle oluşabilen, KARACIğerde fokal formda olmayan değişiklikler meydana getiren geniş bir hastalÕk grubudur.
Journal ArticleDOI

Comparing magnetic resonance liver fat fraction measurements with histology in fibrosis: the difference between proton density fat fraction and tissue mass fat fraction.

TL;DR: In this article , the authors investigated whether a tissue water content correction, as assessed by MRI relaxometry, could provide better agreement between MRI and visual estimates of fat fraction in fibrotic livers.
Journal ArticleDOI

Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity

TL;DR: To investigate the utility of the controlled attenuation parameter (CAP), as measured by a liver elastography technique, in predicting varying degrees of liver steatosis in children with obesity, a large number of children are diagnosed with obesity.
Journal ArticleDOI

Response to Comment on Tang et al. Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Diabetes Care 2015;38:1339-1346.

Abstract: Shan et al. (1) raise important points regarding treatment duration, sample size, mean values of magnetic resonance (MR)-based biomarkers, and severity of liver steatosis in our study (2). The 12-week duration of our study was justified by the exploratory aim to compare two second-line injectable treatment alternatives on liver steatosis as measured by MR-based techniques. To acknowledge that the study duration was too short to address the long-term effects on liver steatosis, we preemptively stated in our discussion that “a longer study would have favored GLP-1 agonist therapy in terms of body weight loss and, possibly, a concomitant reduction in the liver fat fraction” …
Journal ArticleDOI

Morphological characterization of hepatic steatosis and Monte Carlo modeling of MRI signal for accurate quantification of fat fraction and relaxivity

TL;DR: In this paper, the authors proposed a method to generate realistic steatosis models from histology and synthesize MRI signal using Monte Carlo simulations to investigate the accuracy of single-and dual-R2 * models in quantifying FF and R2 * values.
References
More filters
Journal ArticleDOI

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

TL;DR: There are no systems for grading necroinflammatory activity or for staging fibrosis as exist for various other forms of chronic liver disease and this study proposes a grading and staging system that reflects the unique histological features of nonalcoholic steatohepatitis.
Journal ArticleDOI

Sampling variability of liver fibrosis in chronic hepatitis C.

TL;DR: It is suggested that a length of at least 25 mm is necessary to evaluate fibrosis accurately with a semiquantitative score, because variability in the distribution of fibrosis within the liver is a major limitation when using more accurate methods such as automated image analysis.
Journal ArticleDOI

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

TL;DR: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.
Related Papers (5)